Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-06

FDA Approved: HULIO — Original Application (Biocon Biologics Inc)

View source ↗

Summary

FDA approved HULIO (adalimumab-fkjp) from Biocon Biologics Inc via an original Biologics License Application, a biosimilar to adalimumab. The approval enables t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HULIO (ADALIMUMAB-FKJP)

Snippet

ORIG AP for HULIO (ADALIMUMAB-FKJP)